Literature DB >> 32805455

Controversies in Allergy: Chemotherapy Reactions, Desensitize, or Delabel?

David I Hong1, Ricardo Madrigal-Burgaleta2, Aleena Banerji3, Mariana Castells1, Emilio Alvarez-Cuesta4.   

Abstract

Keywords:  Biological agents; Chemotherapy; Delabeling; Drug allergy; Drug challenge; Drug desensitization; Drug provocation tests; Risk stratification; Skin test

Mesh：

Substances：

Year:  2020        PMID： 32805455     DOI： 10.1016/j.jaip.2020.08.005

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  5 in total

1.  Rapid drug desensitization with platin-based chemotherapy: Analysis of risk factors for breakthrough reactions.

Authors:  Begum Gorgulu Akin; Merve Erkoc; Elif Tugce Korkmaz; Betul Ozdel Ozturk; Sevgi Colak; Funda Seher Ozalp Ates; Sevim Bavbek
Journal:  World Allergy Organ J       Date:  2021-12-20       Impact factor: 4.084

2.  Use of Rapid Drug Desensitization in Delayed Hypersensitivity Reactions to Chemotherapy and Monoclonal Antibodies.

Authors:  Arantza Vega; M Isabel Peña; Inés Torrado
Journal:  Front Allergy       Date:  2022-01-14

3.  Analysis of Breakthrough Reactions in 1,143 Desensitization Procedures in a Single Tertiary Hospital Using a One-Bag Desensitization Protocol.

Authors:  Hyun Hwa Kim; Jeongmin Seo; Yoon Hae Ahn; Hyunjee Kim; Jeong-Eun Yoon; Jang Ho Suh; Dong Yoon Kang; Suh Young Lee; Hye-Ryun Kang
Journal:  Front Allergy       Date:  2022-02-11

Review 4.  Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines.

Authors:  Francisca Palomares; Juan L Paris; Marina Labella; Inmaculada Doña; Cristobalina Mayorga; María José Torres
Journal:  Allergy       Date:  2022-08-01       Impact factor: 14.710

Review 5.  Hypersensitivity Reactions to Platinum Agents and Taxanes.

Authors:  Lulu R Tsao; Fernanda D Young; Iris M Otani; Mariana C Castells
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-02       Impact factor: 10.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.